Handan Zincir, Alime Selçuk Tosun, Elif Eliş

Tip 2 diabetes mellitusu olan Türk yetişkinlerde tamamlayıcı ve alternatif tıp ve özetkililik düzeyi

Amaç: Bu çalışma Tip 2 diabetes mellitus’u olan bireylerin kan glikoz kontrolünde uyguladıkları tamamlayıcı ve alternatif tıp (TAT), öz-etkililik düzeyi ve TAT kullanımını etkileyen faktörleri belirlemek amacıyla yapılmıştır. Gereç ve Yöntem: Bu çalışma bir üniversite hastanesinde toplamda 350 diabetes mellitus’u olan birey ile kesitsel olarak yapılmıştır. Verilerin toplanmasında bireylerin tanıtıcı ve hastalık özelliklerini içeren kişisel anket formu, Tip 2 Diyabetlilerde Öz-Etkililik (Yeterlik) Ölçeği ve tamamlayıcı ve alternatif tıp soru formu kullanılmıştır. Bulgular: Çalışmaya katılan tüm bireylerin yaş ortalaması 55.83±8.82 (min:.29-max:.78)’yıldır. Bireylerin TAT kullanım yaygınlığı %38.3 olduğu tespit edilmiştir. Lojistik regresyon analizine göre de öz-etkililik toplam puanı, açlık kan şekeri, hekim kontrolüne 6 ay üzerinde gitmenin TAT kullanma durumu için önemli belirleyiciler olduğu saptanmıştır. Sonuç: Tamamlayıcı ve alternatif tedavilerden özellikle bitkisel ürünlerin yaygın olarak kullanıldığı belirlenmiştir. Hastaların çoğunluğunun rutin kontrollerinde TAT kullanımı ile ilgili sağlık çalışanlarını bilgilendirmedikleri saptanmıştır. Bu açılardan diyabet yönetiminde önemli rolleri olan ve hastayla daha fazla zaman geçiren ve doğrudan bakımlarında görev alan özellikle hemşirelerin TAT kullanım durumunu sorgulamaları, bireylerin de sağlık çalışanlarını TAT kullanımı konusunda bilgilendirmelerinin önemi konusunda vurgu yapmak gerekmektedir.

Complementary and alternative medicine and self-efficacy level in Turkish adults with type 2 diabetes mellitus

Purpose: This study was conducted to determine thecomplementary and alternative medicine (CAM) used forblood glucose control, their self-efficacy level and thefactors affecting the use of CAM. of individuals with type2 diabetes mellitus.Materials and Methods: This cross-sectional study wasconducted with a total of 350 individuals with diabetesmellitus in a university hospital. In order to collect thedata, Personal information form including descriptive anddisease characteristics of the individuals, Self-efficacy Scalefor patients with Type 2 Diabetes, and the complementaryand alternative medicine questionnaire were used.Results: The average age of all individuals participated inthe study was 55.83±8.82 (min:. 29-max:.78) years. Theprevalence CAM use of the patients was 38.3%. Accordingto the logistic regression analysis, self-efficacy total score,fasting blood glucose, and going to physician control after6 months were found to be the important determinantsfor the use of CAM.Conclusion: Especially herbal products from thecomplementary and alternative medicine methods weredetermined to be commonly used. Majority of the patientsdid not inform the healthcare professionals about the useof CAM during their routine controls. In this respect,especially the nurses, who have important roles in diabetesmanagement should question the use of CAM and theimportance of informing the healthcare professionals bythe individuals about the use of CAM should beemphasized.

PDF

___

1. International Council of Nurses (ICN). Delivering Quality, Servering Communities: Nurses Leading Chronic Care. Geneva, Switzerland. 2010. Available at: http://www.icn.ch/publications/2010-deliveringquality-serving-communities-nurses-leading-chroniccare, 2010 (accessed date: 06.04.2018).
2. World Health Organization (WHO). 2010. Global Status Report on Noncommunicable Diseases. Available at: www.who.int/nmh/publications/ncd_report_full_en .pdf (accessed date: 04.04.2018).
3. International Diabetes Federation (IDF). 2017. Diabetes Atlas. 8th edition. Available at: http://diabetesatlas.org/IDF_Diabetes_Atlas_8e_int eractive_EN/ (accessed date: 28.08.2018).
4. American Diabetes Association (ADA). Standards of medical care in diabetes. Diabetes Care. 2017;40:1- 135.
5. Pandey A, Tripathi P, Pandey R, Srivatava R, Goswami S. Alternative therapies useful in the management of diabetes: A systematic review. J Pharm Bioallied Sci. 2011;3:504-12.
6. Hasan SS, Ahgmed SI, Bukhari NI, W.C. Wei Loon. Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics. Complement Ther Clin Pract. 2009;15:152-7.
7. Atwine F, Hultsjö S, Albin B, Hjelm K. Health-care seeking behaviour and the use of traditional medicine among persons with type 2 diabetes in south-western Uganda: a study of focus group interviews. Pan Afr Med J. 2015;29:76.
8. Ryan EA, Pick ME, Marceu C. Use of alternative medicines in diabetes mellitus. Diabet Med. 2000;18:242-5.
9. Hasani-Ranjbar S, Zahedi HS, Abdollahi M, Larijani B. Trends in publication of evidence-based Traditional Iranian medicine in endocrinology and metabolic disorders. J Diabetes Metab Disord. 2013;12:49.
10. İnanç N, Çiçek B, Şahin H, Bayat M, Tasci S. Use of Herbs by the Patients with Diabetes in Kayseri. Pakistan Journal of Nutrition. 2007;6:310-2.
11. Ceylan S, Azal Ö, Taşlipinar A, Türker T, Açikel CH, Gülec M. Complementary and alternative medicine use among Turkish diabetes patients. Complement Ther Med. 2009;17:78-83.
12. Oksel E, Şişman FN. Complementary and alternative therapy method that patients’ use in diabetes mellitus. Journal of Ege University Nursing Faculty. 2009;25:27-36 (In Turkish)
13. Küçükgüçlü Ö, Kızılcı S, Mert H, Uğur Ö, Büyükkaya Besen D, Ünsal E. Complememntary and alternative medicine use among people with diabetes in Turkey. Western Journal of Nursing Research. 2012;34:902-16.
14. Kaynak İ, Polat Ü. Diabetes mellitus’lu hastaların tamamlayıcı ve alternatif tedavileri kullanma durumları ve diyabet tutumları ile ilişkisi. Genel Tıp Dergisi. 2017;27:56-64.
15. Villa-Caballero L, Morello CM, Chynoweth M, Prieto-Rosinol A, Polonsky WH, Palinkas LA, Edelman SV. Ethnic differences in complementary and alternative medicine use among patients with diabetes. Complement Ther Med. 2010;18:241-8.
16. Mohamed H, Abdin J, Al lenjawi B, Al Hamadini Z, Schlogl JM. Use of complementary and alternative medicine among patients with type 2 diabetes mellitus in a newly developing country: a crosssectional study in Qatar. Int J Clin Resh Trial. 2016;2:106.
17. Manya K, Cahmpion B, Dunnig T. The use of complementary and alternative medicine among people living with diabetes in Sydney. BMC Complement and Altern Med. 2012;12:2-5.
18. Ching SM, Zakaria ZA, Paimin F, Jalalian M. Complementary alternative medicine use among patients with type 2 diabetes mellitus in the primary care setting: a cross-sectional study in Malaysia. BMC Complement Altern Med. 2013;13:148-53.
19. Azizi-Fini I, Adib-Hajbagbery M, Gharehbogh Z. Herbal medicine use among patients with type 2 diabetes in Kashan, Iran, 2015. Eur J Integr Med. 2016;8:570-5.
20. Sheikhrabori A, Dehghan M, Ghaedi F, Khademi GR. Complementary and alternative medicine usage and ıts determinant factors among diabetic patients: An Iranian case. Journal of Evidence-Based Complementary & Alternative Medicine. 2017;22:449-54.
21. Chang H, Wallis M, Tiralongo E. Use of complementary and alternative medicine among people living with diabetes: Literature review. J Adv Nurs. 2007;58:307-19.
22. Bell RA, Suerken CK, Grzywacz JG, Lang W, Quandt SA, Arcury TA. Complementary and alternative medicine use among adults with diabetes in the United States. Altern Ther Health Med. 2006;12:16-22.
23. Wazaify M, Afifi FU, El-Khateeb M, Ajlouni K. Complementary and alternative medicine use among Jordanian patients with diabetes. Complement Ther Clin Pract 2011;17:71-5.
24. Redding CA, Rossi JS, Rossi SR, Velicer WF, Prochaska JO. Health behavior models. The International Electronic Journal of Health Education. 2000;3:180-93.
25. Al-Khawaldeh OA, Al-Hassan MA, Froelicher ES. Self-efficacy, self-management, and glycemic control in adults with type 2 diabetes mellitus. J Diabetes Complications. 2012;26:10-6.
26. Gao J, Wang J, Zheng P, Haardörfer R, Kegler MC, Zhu Y, Fu H. Effects of self-care, self-efficacy, social support on glycemic control in adults with type 2 diabetes. BMC Fam Pract. 2013;14:66-72.
27. Walker RJ, Smalls BL, Hernandez-Tejada MA, Campbell JA, Egede LE. Effect of diabetes selfefficacy on glycemic control, medication adherence, self-care behaviors, and quality of life in a predominantly low-income, minority population. Ethn Dis. 2014;24:349-55.
28. Lwanga SK, Lemeshow S. Sample Size Determinationa in Health Studies-A practical Manuel, World Health Organization, Geneva. 1991.
29. Van der Bijl J, Van Poelgeest-Eeltink A, ShortridgeBaggett L. The psychometric properties of the diabetes management self-efficacy scale for patients with type 2 diabetes mellitus. J Adv Nurs. 1999;30:352-9.
30. Kara M, van der Bijl JJ, Shortridge-Bagget LM, Astı T, Erguney S. Cross-cultural adaptation of the diabetes management self-efficacy scale for patients with type 2 diabetes mellitus: Scale development. Int J Nurs Stud. 2006;43:611-21.
31. N. Baharom, S.S. Azhar, A.B. Rotina. Prevalence of complementary alternative medicine use among patients with type ıı diabetes in Negeri Sembilan, Malaysia. Medicine & Health. 2016;11:257-66.
32. Aydin S, Bozkaya AO, Mazicioglu M, Gemalmaz A. Özçakir A, Öztürk A. What influences herbal medicine use? Prevalence and related factors. Turk J Med Sci. 2008;38:455-63.
33. Ali BAM, Mahfouz MS. Herbal medicine use among patients with type 2 diabetes in North Sudan. Ann Res Rev Biol. 2014;4:1827-38.
34. Tackett KL, Jones MC. Complementary and alternative medicine for the treatment of diabetes. J of Pharmacy Practice. 2009;22:546-52.
35. Posadzki P, Watson LK, Ernst E. Adverse effects of herbal medicines: An overview of systematic reviews. Clinical Medicine. 2013;13:7-12.
36. Bahmani M, Zargaran A, Rafieian-Kopaei M, Kourosh S. Ethnobotanical study of medicinal plants used in the management of diabetes mellitus in the Urmia, Northwest Iran. Asian Pac J Trop Med. 2014;7:348-54.
37. Bnouham M, Merhfour FZ, Ziyyat A, Mekhfi H, Aziz M, Legssyer A. Antihyperglycemic activity of the aqueous extract of Urtica. Fitoterapia.2003;74:677-81.
38. Farzami B, Ahmadvand D, Vardasbi S, Majin FJ, Khaghani SH. Induction of insulin secretion by a component of Urticadioica leave extract in perifused Islets of Langerhans and its in vivo effects in normal and streptozotocin diabetic rats. J Ethnopharmacol. 2003;89:47-53.
39. Ahangarpour A, Mohammmadian M, Dianat M. Antidiabetic effect of hydroalcholic urtica dioica leaf extract in male rats with fructose-ınduced ınsulin resistance. Iran J Med Sci. 2012;37:181-6.
40. Kan J, Velliquette RA, Grann K, Burns CR, Scholten J, F. Q. Tian, Zhang, M. Gui. A novel botanical formula prevents diabetes by improving insulin resistance. BMC Complement Altern Med. 2017;17:352.
41. Khalaf AJ, Whitford DL. The use of complementary and alternative medicine by patients with diabetes mellitus in Bahrain:a cross-sectional study. BMC Complement and Altern Med. 2010;10:35.
42. Ogbera AO, Dada O, Adeleye F, Jewo PI. Complementary and alternative medicine use in diabetes mellitus. WAJM. 2010;29:158-162.
43. Bradley R, Sherman KJ, Catz S, Calabrese C, Jordan L, Grothaus L, Cherkin DC. Survey of CAM interest, self-care, and satisfaction with health care for type 2 diabetes at group health cooperative. BMC Complement Altern Med. 2011;11:121.
44. Türkiye Endokrinoloji ve Metabolizma Derneği (TEMD) Diabetes Mellitus ve Komplikasyonlarının Tanı, Tedavi ve İzlem Kılavuzu-2018, TEMD Diabetes Mellitus Çalışma ve Eğitim Grubu. 10. Baskı, Miki Matbaacılık, Ankara, 2018.